Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression

Clinical trial NCT03833063 · WITHDRAWN

Trial details

NCT number: NCT03833063
Sponsor: Helse Stavanger HF
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder Major Depressive Episode Treatment Resistant Depression

Start date: 2019-05-01
Primary completion: 2019-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.